Vaishali Pharma Limited
NSE: VAISHALI.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hemanth Damodar Pathak
- Employees
- 27
- Headquarters
- Mumbai, India
- IPO year
- 2017
- Market cap
- ₹800.7M
- Website
- https://www.vaishalipharma.com
Loading VAISHALI…
Loading profile data…Frequently asked questions about VAISHALI
What does Vaishali Pharma Limited (VAISHALI.NS) do?
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, ant...
Where does VAISHALI.NS trade?
Vaishali Pharma Limited (VAISHALI.NS) trades on the National Stock Exchange of India.
What sector is VAISHALI.NS in?
Vaishali Pharma Limited (VAISHALI.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Vaishali Pharma Limited?
Hemanth Damodar Pathak is the chief executive officer of Vaishali Pharma Limited (VAISHALI.NS).
Where is Vaishali Pharma Limited headquartered?
Vaishali Pharma Limited is headquartered in India.
Does VAISHALI.NS pay a dividend?
Vaishali Pharma Limited (VAISHALI.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VAISHALI.NS go public?
Vaishali Pharma Limited (VAISHALI.NS) completed its initial public offering in 2017.